Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A standardized care pathway increases optimal dialysis starts.
Marcus RG, Miller DM, Nathanson BH, Eckhardt D, Henry S, Kwon K, Sharma R, Vakharia N. Marcus RG, et al. Among authors: henry s. Am J Manag Care. 2024 Dec 1;30(12):e345-e351. doi: 10.37765/ajmc.2024.89642. Am J Manag Care. 2024. PMID: 39745500 Free article.
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
De Jaeghere EA, Tuyaerts S, Van Nufel AMT, Belmans A, Bogaerts K, Baiden-Amissah R, Lippens L, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Denys HG. De Jaeghere EA, et al. Among authors: henry s. Cancer Immunol Immunother. 2024 Dec 30;74(1):32. doi: 10.1007/s00262-024-03873-5. Cancer Immunol Immunother. 2024. PMID: 39738642 Free PMC article. No abstract available.
Some Human Anti-Glycan Antibodies Lack the Ability to Activate the Complement System.
Shilova N, Nokel A, Lipatnikov A, Khasbiullina N, Knirel Y, Baidakova L, Tuzikov A, Khaidukov S, Obukhova P, Henry S, Shoibonov B, Salimov E, Rieben R, Bovin N. Shilova N, et al. Among authors: henry s. Antibodies (Basel). 2024 Dec 23;13(4):105. doi: 10.3390/antib13040105. Antibodies (Basel). 2024. PMID: 39727488 Free PMC article.
Long COVID-19 outcomes of patients with pre-existing dementia.
Hadidchi R, Pakan R, Alamuri T, Cercizi N, Al-Ani Y, Wang SH, Henry S, Duong TQ. Hadidchi R, et al. Among authors: henry s. J Alzheimers Dis. 2024 Dec 16:13872877241303934. doi: 10.1177/13872877241303934. Online ahead of print. J Alzheimers Dis. 2024. PMID: 39686622
Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024.
Ploin D, Alexandre M, Ventelou B, Che D, Coignard B, Boulanger N, Burucoa C, Caron F, Gallian P, Hansmann Y, Lienhardt C, Minodier P, Partouche H, Revest M, Saidani N, Salvat G, Vignier N, Floreani S; Collaborators’ group; Henry S, Pozzetto B, Hoen B; Experts of the criteria weighting group (alphabetically) Experts of the entity rating group (alphabetically) Experts from Santé publique France who provided the quantitative data (alphabetically). Ploin D, et al. Among authors: henry s. Euro Surveill. 2024 Dec;29(50):2400074. doi: 10.2807/1560-7917.ES.2024.29.50.2400074. Euro Surveill. 2024. PMID: 39668764 Free PMC article.
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin.
Dul M, Alali M, Ameri M, Burke MD, Creelman BP, Dick L, Donnelly RF, Eakins MN, Frivold C, Forster AH, Gilbert PA, Henke S, Henry S, Hunt D, Lewis H, Mistilis JJ, Park JH, Prausnitz MR, Robinson DK, Hernandez CAR, Shin J, Speaker TJ, Strasinger C, Taylor KMG, Zehrung D, Birchall JC, Jarrahian C, Coulman SA. Dul M, et al. Among authors: henry s. J Control Release. 2024 Dec 20;378:402-415. doi: 10.1016/j.jconrel.2024.11.056. Online ahead of print. J Control Release. 2024. PMID: 39603537 Free article.
1,555 results